Express Scripts

Eli Lilly says it's cutting an average of 50% off list prices—and its price hikes don't work

In quick rebuttal, Express Scripts blasts Gilead exec's pricing blame

Gilead's hep C pain helps the rest of pharma on drug spending: analyst

PBMs counter pharma's pricing blame with proposals to cut $100B in drug costs

New cancer drugs offer widely different benefits, study says